Late onset asymptomatic pancreatic neuroendocrine tumor – A case report on the phenotypic expansion for MEN1
Published on: 21 July 2017
Published on: 28 June 2017
ARLTS1 polymorphism is associated with an increased risk of familial cancer: evidence from a meta-analysis
Published on: 13 June 2017
Published on: 25 May 2017
Aims and scope
Hereditary Cancer in Clinical Practice is an open access journal that publishes articles of interest for the cancer genetics community and serves as a discussion forum for the development appropriate healthcare strategies.
Cancergenetics encompasses a wide variety of disciplines and knowledge in the field is rapidly growing, especially as the amount of information linking genetic differences to inherited cancer predispositions continues expanding. With the increased knowledge of genetic variability and how this relates to cancer risk there is a growing demand not only to disseminate this information into clinical practice but also to enable competent debate concerning how such information is managed and what it implies for patient care.
Topics covered by the journal include but are not limited to:
- Original research articles on any aspect of inherited predispositions to cancer.
- Reviews of inherited cancer predispositions.
- Application of molecular and cytogenetic analysis to clinical decision making.
- Clinical aspects of the management of hereditary cancers.
- Genetic counselling issues associated with cancer genetics.
- The role of registries in improving health care of patients with an inherited predisposition to cancer.
Meet the Editors-in-Chief
Jan Lubinski is a Professor of Medicine and Head of the International Hereditary Cancer Center (organized in 1992) of Pomeranian Medical University in Szczecin, Poland. The center conducted the first world-wide population screening for cancer family syndromes in a 1.7 million region of West-Pomerania, Poland in 2000-2001. It has a network of outpatient clinics covering almost the entire country as well as a cancer bio-bank with biological samples and clinical data from 250,000 cancer cases and appropriate controls, which includes registries of thousands of mutation carriers.
Rodney J Scott graduated from the University of Western Australia, Australia with a PhD in cellular biology and subsequently worked in the Department of Pathology and Laboratory Medicine at the University of Texas in Houston and then at the Centre for Teaching and Learning at the University of Basel, Switzerland. Since 1999 Prof. Scott has been a visiting Professor at the International Hereditary Cancer Center in Szczecin, Poland and more recently has been appointed as a adjunct Professor at the Universiti Kebangsaan Malaysia.
Rolf Sijmons has worked as a clinical geneticist in the field of oncogenetics for more than 20 years. He is Consultant in Clinical Oncogenetics and Professor of Medical Translational Genetics at the University Medical Center Groningen, the Netherlands. His research interests mainly focus on the genetics of colorectal cancer, the clinical interpretation of unclassified variants, bioinformatics tools to support clinical management of cancer families and clinical applications of nextgen sequencing technology. He is member of several international committees in these fields and is editor of the familial cancer database.